Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2022-03-29Clinical Trial Update: Cost-effectiveness Analysis Between Two Anticoagulation Strategies for Atrial Fibrillation in the Postoperative Period of Coronary Artery Bypass Graft Surgery [Phase 4]
Phase 4 cost-effectiveness analysis comparing two anticoagulation strategies for new-onset atrial fibrillation after coronary artery bypass …
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: MODULA Modul 7 VRR [NA]
Clinical trial update for MODULA Modul 7 VRR in atrial fibrillation; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) [Phase 3]
Phase 3 trial comparing edoxaban to standard care after transcatheter aortic valve implantation in patients with atrial fibrillation has com…
-
CLINICAL_TRIALS trial_result · 2022-03-21Clinical Trial Update: A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers [Phase 4]
Phase 4 trial examining how rabeprazole-induced higher stomach pH affects APO-dabigatran exposure in healthy volunteers.
-
FDA approval · 2022-03-21FDA Approved: ESMOLOL HYDROCHLORIDE — Original Application (Eugia US LLC)
FDA approved the original application for esmolol hydrochloride in sodium chloride injection, a generic product manufactured by Eugia US LLC…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: Multi_center Study to Evaluate the Effect of N-3 Fatty Acids (OMEGA-3) on Arrhythmia Recurrence in Atrial Fibrillation [Phase 3]
Phase 3 trial evaluating omega-3 fatty acids for atrial fibrillation recurrence has been completed.
-
FDA approval · 2022-03-17FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved the original Abbreviated New Drug Application for verapamil hydrochloride from Heritage Pharmaceuticals (d/b/a Avet) as a gener…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Spanish Registry of Cryoballoon Ablation
Update on the Spanish Registry of Cryoballoon Ablation for atrial fibrillation: the trial status is completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: VAscular Closure for Cardiac Ablation Registry (VACCAR)
A completed clinical trial registry entry for VACCAR studying vascular closure after cardiac ablation in atrial fibrillation patients; resul…
-
FDA approval · 2022-03-11FDA Approved: DIGOXIN — Original Application (Amici Pharma, Inc)
FDA approved the original ANDA for digoxin from Amici Pharma, authorizing a generic digoxin product.
-
FDA approval · 2022-02-08FDA Approved: DIGOXIN — Original Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's original application for a generic digoxin product, enabling marketing in the United States.
-
CLINICAL_TRIALS trial_result · 2022-02-07Clinical Trial Update: Comparison of Percutaneous Closure to Manual Compression for Hemostasis [NA]
A completed clinical trial comparing percutaneous closure to manual compression for hemostasis in atrial fibrillation patients; results post…
-
CLINICAL_TRIALS trial_result · 2022-02-07Clinical Trial Update: To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation [Phase 4]
Phase 4 trial evaluating the impact of oral flecainide on quality of life in patients with atrial fibrillation has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-07Clinical Trial Update: Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation. [Phase 4]
Phase 4 trial update comparing flecainide CR to placebo in early treatment of atrial fibrillation; study terminated.
-
CLINICAL_TRIALS trial_result · 2022-01-25Clinical Trial Update: Junctional AV Ablation in CRT-D: JAVA-CRT [NA]
A completed clinical trial (JAVA-CRT) evaluating junctional AV ablation in CRT-D for patients with systolic heart failure and permanent atri…
-
CLINICAL_TRIALS trial_result · 2022-01-25Clinical Trial Update: SDM for Stroke Prevention in Atrial Fibrillation [NA]
A completed clinical trial from Mayo Clinic on stroke prevention in atrial fibrillation has results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Feasibility and Safety of IV Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy [Phase 4]
A Phase 4 trial assessing feasibility and safety of giving IV sotalol as a loading dose to start oral sotalol therapy for arrhythmias and at…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Femoral Vein Hemostasis After Ablation for Atrial Fibrillation With Manual Pressure Versus a Figure of 8 Suture [NA]
A completed clinical trial comparing femoral vein hemostasis methods after atrial fibrillation ablation (manual pressure vs. figure-of-8 sut…
-
CLINICAL_TRIALS trial_result · 2022-01-05Clinical Trial Update: Rate Control in Atrial Fibrillation II [Phase 4]
Phase 4 clinical trial update on rate control in atrial fibrillation, completed.
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure [Phase 2, Phase 3]
Phase 2/3 trial comparing dual antiplatelet therapy with rivaroxaban in atrial fibrillation patients undergoing left atrial appendage closur…
-
CLINICAL_TRIALS trial_result · 2021-12-21Clinical Trial Update: Esophageal Cooling for AF Ablation [NA]
Clinical trial investigating esophageal cooling during atrial fibrillation ablation has completed with results posted.
-
FDA approval · 2021-12-20FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
The FDA approved a supplemental application for Hospira's verapamil hydrochloride under an existing approved product, marking an update to t…
-
CLINICAL_TRIALS withdrawal · 2021-12-15Clinical Trial Update: Assessment of Intravenous Rate Control Response in Atrial Fibrillation Trial (AIRCRAFT) [Phase 4]
Phase 4 trial AIRCRAFT evaluating intravenous rate control in atrial fibrillation has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-12-07Clinical Trial Update: A Dose-range Finding Study of MAA868 in Patients With Atrial Fibrillation [Phase 2]
Phase 2 dose-range finding study of MAA868 in atrial fibrillation completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With Medicare
A completed clinical trial evaluating the effectiveness and safety of oral anticoagulants in obese patients with non-valvular atrial fibrill…